Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON22558Active, not recruiting
Open-label, single-arm trial of propofol in traumatic brain injury (TBI), sponsored by University Medical Center Groningen. Primary endpoint: Pharmacokinetic and pharmacodynamic parameters. Started Jan 2006; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON22558.